Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults

Clin Interv Aging. 2023 Jan 12:18:49-59. doi: 10.2147/CIA.S361519. eCollection 2023.

Abstract

Exogenous melatonin is commonly used for sleep disorders in older adults, and its use is increasing over time. It appears to have modest efficacy in treating insomnia and circadian rhythm sleep-wake disorders. Melatonin is commonly perceived to be a safe alternative to other hypnotics and is available without prescription in some jurisdictions. New evidence suggests that endogenous melatonin has pleomorphic effects on multiple organ systems, many of which are poorly understood. This narrative review summarizes the current evidence regarding the safety of melatonin in older adults (defined by age over 65 years). Melatonin appears to have a favorable safety profile in this population, however there is a dearth of evidence regarding the safety of prolonged use. There are several factors which increase the risk of adverse effects of melatonin in older adults, and these should be taken into consideration when prescribing to this population.

Keywords: adverse effect; elderly; insomnia; safety; sleep wake phase disorder.

Publication types

  • Review

MeSH terms

  • Aged
  • Circadian Rhythm
  • Humans
  • Hypnotics and Sedatives / adverse effects
  • Melatonin* / adverse effects
  • Sleep
  • Sleep Disorders, Circadian Rhythm* / drug therapy
  • Sleep Initiation and Maintenance Disorders* / drug therapy
  • Sleep Wake Disorders* / drug therapy

Substances

  • Melatonin
  • Hypnotics and Sedatives